AFMID
Basic information
Region (hg38): 17:78187358-78207702
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AFMID gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 24 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 4 | 0 |
Variants in AFMID
This is a list of pathogenic ClinVar variants found in the AFMID region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-78187374-A-G | not specified | Uncertain significance (Nov 13, 2023) | ||
17-78191004-T-C | not specified | Uncertain significance (Oct 12, 2021) | ||
17-78191010-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
17-78202595-C-T | not specified | Uncertain significance (Jun 22, 2023) | ||
17-78202747-G-A | not specified | Uncertain significance (Mar 21, 2023) | ||
17-78204678-G-C | not specified | Uncertain significance (Aug 12, 2021) | ||
17-78204724-A-G | not specified | Uncertain significance (May 27, 2022) | ||
17-78204726-G-A | not specified | Uncertain significance (Apr 13, 2023) | ||
17-78204831-C-A | not specified | Uncertain significance (Sep 16, 2021) | ||
17-78204840-A-G | not specified | Uncertain significance (Jan 20, 2023) | ||
17-78204851-C-A | not specified | Uncertain significance (Aug 13, 2021) | ||
17-78205145-C-T | not specified | Uncertain significance (Apr 25, 2022) | ||
17-78205451-G-A | not specified | Uncertain significance (Apr 10, 2023) | ||
17-78205451-G-C | not specified | Uncertain significance (Jun 18, 2021) | ||
17-78205481-G-A | not specified | Likely benign (Aug 12, 2021) | ||
17-78205487-A-G | not specified | Uncertain significance (Dec 02, 2022) | ||
17-78205492-A-G | Likely benign (May 01, 2022) | |||
17-78205653-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
17-78205671-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
17-78205685-G-A | not specified | Uncertain significance (Nov 15, 2023) | ||
17-78205698-A-T | not specified | Uncertain significance (Jan 26, 2022) | ||
17-78205962-A-G | not specified | Likely benign (Dec 09, 2023) | ||
17-78206002-C-G | not specified | Uncertain significance (Sep 25, 2023) | ||
17-78206009-A-G | not specified | Uncertain significance (Jun 29, 2022) | ||
17-78206026-C-T | Likely benign (Apr 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AFMID | protein_coding | protein_coding | ENST00000327898 | 11 | 20385 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.50e-9 | 0.593 | 125295 | 2 | 451 | 125748 | 0.00180 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.124 | 181 | 186 | 0.974 | 0.0000108 | 1995 |
Missense in Polyphen | 59 | 60.208 | 0.97994 | 648 | ||
Synonymous | 0.224 | 77 | 79.5 | 0.968 | 0.00000565 | 589 |
Loss of Function | 1.20 | 16 | 22.1 | 0.724 | 0.00000120 | 222 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00243 | 0.00243 |
Ashkenazi Jewish | 0.000198 | 0.000198 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.000284 | 0.000277 |
European (Non-Finnish) | 0.00310 | 0.00308 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.000426 | 0.000425 |
Other | 0.00147 | 0.00147 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. {ECO:0000255|HAMAP-Rule:MF_03014}.;
- Pathway
- Tryptophan metabolism - Homo sapiens (human);Glyoxylate and dicarboxylate metabolism - Homo sapiens (human);Tryptophan Metabolism;NAD Biosynthesis II (from tryptophan);Tryptophan metabolism;Tryptophan catabolism;Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism;Metabolism of amino acids and derivatives;tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde;Metabolism;L-kynurenine degradation;NAD <i>de novo</i> biosynthesis;Tryptophan degradation;superpathway of tryptophan utilization;tryptophan degradation
(Consensus)
Recessive Scores
- pRec
- 0.218
Intolerance Scores
- loftool
- 0.378
- rvis_EVS
- 0.62
- rvis_percentile_EVS
- 83.36
Haploinsufficiency Scores
- pHI
- 0.0656
- hipred
- N
- hipred_score
- 0.169
- ghis
- 0.411
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.902
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Afmid
- Phenotype
- homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; renal/urinary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- tryptophan catabolic process to kynurenine;'de novo' NAD biosynthetic process from tryptophan
- Cellular component
- nucleus;cytoplasm;cytosol
- Molecular function
- arylformamidase activity